These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19774532)

  • 1. [Duchenne muscular dystrophy: current aspects and perspectives on treatment].
    López-Hernández LB; Vázquez-Cárdenas NA; Luna-Padrón E
    Rev Neurol; 2009 Oct 1-15; 49(7):369-75. PubMed ID: 19774532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A current approach to heart failure in Duchenne muscular dystrophy.
    D'Amario D; Amodeo A; Adorisio R; Tiziano FD; Leone AM; Perri G; Bruno P; Massetti M; Ferlini A; Pane M; Niccoli G; Porto I; D'Angelo GA; Borovac JA; Mercuri E; Crea F
    Heart; 2017 Nov; 103(22):1770-1779. PubMed ID: 28668906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the quality of life of children with Duchenne's progressive muscular dystrophy].
    Longo-Araujo de Melo E; Moreno-Valdes MT
    Rev Neurol; 2007 Jul 16-31; 45(2):81-7. PubMed ID: 17642047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales.
    Davis SE; Hynan LS; Limbers CA; Andersen CM; Greene MC; Varni JW; Iannaccone ST
    J Clin Neuromuscul Dis; 2010 Mar; 11(3):97-109. PubMed ID: 20215981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
    Spurney CF
    Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.
    Birnkrant DJ; Bushby K; Bann CM; Alman BA; Apkon SD; Blackwell A; Case LE; Cripe L; Hadjiyannakis S; Olson AK; Sheehan DW; Bolen J; Weber DR; Ward LM;
    Lancet Neurol; 2018 Apr; 17(4):347-361. PubMed ID: 29395990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy.
    Borrelli O; Salvia G; Mancini V; Santoro L; Tagliente F; Romeo EF; Cucchiara S
    Am J Gastroenterol; 2005 Mar; 100(3):695-702. PubMed ID: 15743370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duchenne muscular dystrophy.
    Annexstad EJ; Lund-Petersen I; Rasmussen M
    Tidsskr Nor Laegeforen; 2014 Aug; 134(14):1361-4. PubMed ID: 25096430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the management of Duchenne muscular dystrophy.
    Manzur AY; Kinali M; Muntoni F
    Arch Dis Child; 2008 Nov; 93(11):986-90. PubMed ID: 18667451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines of National Consultant in the issue of cardiologic care of patients with Duchenne's and Becker's muscular dystrophy and cardiomyopathy prevention in woman with DMD/BMD mutations (mothers and sisters of patients with dystrophies].
    Sinkiewicz W; Droźdź J; Dubiel JS; Filipiak KJ; Rozentryt P; Wierzchowiecki M; Opolski G
    Kardiol Pol; 2007 Feb; 65(2):223-28. PubMed ID: 17563944
    [No Abstract]   [Full Text] [Related]  

  • 12. Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level?
    Helderman-van den Enden AT; van den Bergen JC; Breuning MH; Verschuuren JJ; Tibben A; Bakker E; Ginjaar HB
    Clin Genet; 2011 Mar; 79(3):236-42. PubMed ID: 21070212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Duchenne muscular dystrophy: rational basis, state of the art].
    Palmieri B; Sblendorio V
    Recenti Prog Med; 2006 Sep; 97(9):441-7. PubMed ID: 17017293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management of Duchenne muscular dystrophy in the Middle East: expert report.
    Jumah MA; Muhaizea MA; Rumayyan AA; Saman AA; Shehri AA; Cupler E; Jan M; Madani AA; Fathalla W; Kashyape P; Kodavooru G; Thihli KA; Bastaki L; Megarbane A; Skrypnyk C; Zamani G; Tuffery-Giraud S; Urtizberea A; Ortez González CI
    Neurodegener Dis Manag; 2019 Jun; 9(3):123-133. PubMed ID: 31166138
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of therapy for Duchenne muscular dystrophy.
    Zhang S; Xie H; Zhou G; Yang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy.
    Kohler M; Clarenbach CF; Böni L; Brack T; Russi EW; Bloch KE
    Am J Respir Crit Care Med; 2005 Oct; 172(8):1032-6. PubMed ID: 15961695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
    Pradhan S
    Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon-skipping therapy for Duchenne muscular dystrophy.
    Nakamura A; Takeda S
    Neuropathology; 2009 Aug; 29(4):494-501. PubMed ID: 19486303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.
    Desguerre I; Mayer M; Leturcq F; Barbet JP; Gherardi RK; Christov C
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):762-73. PubMed ID: 19535995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.